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ABSTRACT 
This study evaluated the effects of the pre-exercise (30 minutes) ingestion of galactose (Gal) or 
glucose (Glu) on endurance capacity as well as glycaemic and insulinaemic responses. Ten 
trained male cyclists completed three randomised high-intensity cycling endurance tests. Thirty 
minutes prior to each trial cyclists ingested 1 litre of either 40g of glucose, 40g of galactose, or a 
placebo in a double blind manner. The protocol comprised: 20 minutes of progressive 
incremental exercise (70% to 85% maximal power output (Wmax)); ten 90 second bouts at 90% 
Wmax, separated by 180 seconds at 55% Wmax; 90% Wmax until exhaustion. Blood samples were 
drawn throughout the protocol. Times to exhaustion were longer with Gal (68.7±10.2 minutes, 
P=0.005) compared to Glu (58.5±24.9 minutes), with neither being different to placebo 
(63.9±16.2 minutes). Twenty-eight minutes following Glu consumption, plasma glucose and 
serum insulin concentrations were higher than with Gal and placebo (P<0.001). Following the 
initial 20 minutes of exercise, plasma glucose concentrations increased to a relative 
hyperglycaemia during the Gal and placebo, compared to Glu condition. Higher plasma glucose 
concentrations during exercise, and the attenuated serum insulin response at rest, may explain the 
significantly longer times to exhaustion produced by Gal compared to Glu. However, neither 
carbohydrate treatment produced significantly longer times to exhaustion than placebo, 
suggesting that the pre-exercise ingestion of galactose and glucose alone is not sufficient to 
support this type of endurance performance.  
Key Words: carbohydrate; galactose; glucose; endurance capacity; rebound hypoglycaemia; pre-
exercise ingestion.  
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INTRODUCTION 
Pre-exercise muscle and liver glycogen concentrations are essential substrate sources 
during prolonged moderate to high-intensity exercise, as they are both directly associated with 
performance (1, 2). Athletes typically consume carbohydrates (CHO) prior to and/or during 
exercise as a means of improving performance and endurance capacity. The exogenous source of 
CHO is likely to maintain higher plasma glucose concentrations and a high rate of CHO 
oxidation, especially late in exercise when muscle and liver glycogen concentrations are 
becoming depleted (7). There is good evidence that actual blood glucose concentration and 
glucose flux into muscle to sustain energy demand during exercise is a primary determinant of 
capacity such that optimal rates are possible only at sufficient blood glucose concentration and 
adequate glycogen reserve (19). Pre-exercise strategies often include the consumption of CHO 
formulations that may include pure glucose or substances that are easily assimilated to glucose, 
within the hour before the commencement of exercise. The pre-exercise ingestion of  glucose in 
comparison to placebo has been shown  to have both negative (15, 28) and positive (40, 41) 
effects on endurance performance,  as well as providing no additional benefit (3, 24, 43).  Some 
of these findings may be reconciled since glucose ingestion can be associated with the 
occurrence of rebound hypoglycaemia during subsequent exercise (23, 29), which may limit the 
ability to enhance endurance performance.  
There is evidence that not all individuals appear to be susceptible to rebound 
hypoglycaemia  (23, 29) and some are even able to maintain endurance performance despite 
transient hypoglycaemic episodes (14). However, previous studies have variably defined 
hypoglycaemia, with thresholds of <2.5 mmol.l-1 (14, 39), ≤3.0 mmol.l-1 (29, 33) and ≤3.5 
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mmol.l-1 (15, 23), making interpretation of susceptibility difficult. Defining rebound 
hypoglycaemia as a plasma glucose concentration 3.0 mmol.l-1 is most appropriate in a 
continuous cycling context as it is consistent with definitions of symptomatic hypoglycaemia 
(12, 33).  
Rebound hypoglycaemia is associated with the occurrence of hyperinsulinaemia, 
typically shown directly prior to exercise (6, 15). As a consequence of hyperinsulinaemia, 
hepatic glucose output (27) and fat oxidation (21) can be suppressed. These transient metabolic 
disturbances, at the start of exercise, as well as mechanisms that increase glycogen utilisation (6, 
17), may explain why pre-exercise glucose does not always provide an additional benefit in 
comparison to placebo. Regardless, there now appears to be less concern about the efficacy and 
use of simple sugars in the hour prior to exercise (18, 22, 26) despite early reservations regarding 
rebound hypoglycaemia (6, 15). If rebound hypoglycaemia is relevant to endurance performance 
the use of other forms of CHO, such as galactose, with a low glycaemic index (GI: ~20), which 
has no primary insulin drive (37), may overcome the issue. Galactose consumption would 
therefore be unlikely to inhibit hepatic output, but maintain fat oxidation, protecting the absorbed 
CHO for later use. Further, the consumption of galactose within the hour before exercise may 
have the potential to pre-load the liver with newly synthesised glycogen, for subsequent release, 
as galactose has to be converted by the liver through the Leloir pathway. This is of particular 
importance as the liver is as important in sustaining high-intensity exercise as muscle glycogen 
(2).  
Only three studies have investigated the effects of galactose on endurance performance 
(24, 31, 42). Of these, only one (24) has specifically examined the pre-exercise ingestion (45 
minutes prior to exercise) of galactose. This showed that there were no significant differences in 
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time trial performance between galactose (mean 42.04 ± 1.4 minutes) and glucose (mean 41.05 ± 
2.9 minutes). The use of a time trial protocol is physiologically  valid (9)  and is likely to detect 
small but potentially crucial differences. However, with a small sample size (n=8) this study may 
have lacked adequate statistical power (calculated to be ~0.3). Therefore, further research is 
required to establish whether or not galactose may be a useful alternative pre-exercise substrate.  
The purpose of the study was to compare the effects of the pre-exercise ingestion (30 
minutes prior to exercise) of galactose and glucose on endurance capacity using a high-intensity 
endurance cycling test, as well as the glycaemic and insulinaemic responses at rest and during 
exercise. The pre-exercise ingestion of galactose has been shown to produce greater stability in 
plasma insulin and glucose concentrations (24), a more progressive glucose oxidation response 
during exercise, as well as sparing pre-existing liver glycogen stores (34), which may be 
beneficial for prolonged exercise performance. Therefore, we hypothesised that an initial bolus 
of galactose 30 minutes before exercise would sustain high-intensity endurance cycling capacity 
more effectively than glucose. In addition, we hypothesized that the pre-exercise ingestion of 
galactose would reduce the occurrence of rebound hypoglycaemia compare to glucose ingestion.  
 
METHODS 
Experimental Approach to the Problem 
Cyclists completed three experimental trials of a variable high-intensity endurance 
cycling test to exhaustion  (35); each test separated by 7 days. This exercise protocol was chosen 
as competitive endurance cycling is characterised by high-intensity efforts interspersed with 
sustained steady state exercise (36, 44) rather than constant load tests. Each trial involved the 
ingestion (30 minutes before exercise) of either 40g of galactose (Gal, (D-galactose, Inalco, 
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Milano, Italy), 40g of glucose (Glu, D-glucose, Cargill, Manchester, United Kingdom) or a 
placebo (water), as 1 litre formulations, using a randomised, double blind experimental design. 
Each cyclist was randomly assigned the order they would complete the experimental trials and 
followed their fixed sequence. All formulations contained 26 mmol·L-1 sodium chloride, as well 
as sweetener and flavouring to blind the participants to each condition. None of the cyclists 
reported that they recognised the placebo.  
 
Subjects 
Ten trained male cyclists, aged: 31 ± 7 years (range 24-44 years), with a body mass of 
76.2 ± 5.0 kg, body fat percentage of 9.7 ± 4.6% (BOD POD®, COSMED USA, Inc., Chicago, 
Illinois, USA), 2OV max of 58.1 ± 5.6 ml·kg-1·min-1 and maximal power output (Wmax) of 364.3 ± 
20.5 watts (W) participated in this study. The cyclists had trained for ≥15 hours per week, for at 
least the last 3 years, were competitive club level road racers, and in a maintenance phase of 
training throughout the duration of the study. The experimental procedures were fully explained 
to each cyclist prior to the study and all cyclists provided written informed consent. The protocol 
employed during this investigation received institutional ethical approval and was performed in 
accordance with the ethical standards specified by the Declaration of Helsinki (1964). 
 
Procedures 
Preliminary Testing 
Cyclists completed a familiarization ride to allow habituation to the laboratory equipment 
and procedures employed (35). A week later the cyclists completed a maximal incremental cycle 
test to volitional exhaustion to determine their individual Wmax (30). This preceded the 
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experimental trials by at least one week. Wmax was used to determine the relative exercise 
intensities to be undertaken by each cyclist during the experimental trials (viz. power output (W) 
at a given % Wmax). All exercise testing was performed on a standardized adjustable road bicycle 
fitted with SRM Powermeters (SRM, Germany) mounted on an air braked cycle ergometer 
(Kingcycle® Ltd, High Wycombe, U.K.). The Kingcycle® was calibrated as described by 
Schabort et al. (38). The SRM Powermeters, calibrated prior to the study, enabled high precision 
(manufacturers technical error <0.5 %) measurements of power output (W).  
 
Experimental Trials 
Cyclists were asked to record their food intakes and activity patterns during the 72-h prior 
to the first experimental trial. They were then instructed to repeat this diet and activity pattern for 
the remaining trials. Cyclists were also instructed to refrain from any strenuous activity, alcohol 
or caffeine consumption in the previous 24-h.  
Following an overnight fast (≥12-h) each cyclist commenced his experimental trials at the 
same time of day (between 0600 and 0900) to avoid any influence of circadian variability. All 
trials were performed under normal environmental conditions (temperature: 18 oC, relative 
humidity; 60%). Upon arrival at the laboratory, a catheter was inserted into an antecubital vein 
for repeated blood sampling. Resting venous blood samples were drawn, at -5 minutes and -2 
minutes prior to fluid consumption and analyzed for plasma glucose, plasma lactate and serum 
insulin concentrations.   
Thirty minutes prior to exercise, participants consumed either the Gal, Glu or placebo 
formulation. Venous blood samples were drawn at 13, 18, 23 and 28 minutes following fluid 
consumption. Cyclists then completed four 5 minutes continuous progressive workload 
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increments corresponding to 70%, 75%, 80% and 85% Wmax. This was followed by ten 90 
second sprints at 90% Wmax, separated by 180 seconds recovery at 55% Wmax  (35). Venous 
blood samples were drawn and heart rate and ratings of perceived exertion (RPE) were recorded 
throughout the exercise period.  
If a cyclist completed all 10 sprints, following a 180 seconds interval at 55% Wmax, 
cycling to volitional exhaustion was undertaken at 90% Wmax. Exhaustion was defined as an 
inability to maintain power output within 5 W of that required and an inability to restore this 
within 15 seconds despite verbal encouragement. The same criteria were applied constantly 
throughout the protocol to ensure the maintenance of the prescribed power outputs. No feedback 
on elapsed time or heart rate was provided to prevent potential bias from cyclists targeting 
previous times or heart rates. 
Blood Analyses  
Blood samples drawn for both plasma glucose and plasma lactate measurements were 
collected in fluoride oxalate containing tubes (Becton Dickinson, Oxford, UK), while those for 
serum insulin were collected in plain tubes (Becton Dickinson, UK). Blood samples were stored 
on ice and centrifuged with aliquots of plasma and serum then being analysed for selected 
metabolites. Plasma glucose (Glucose Oxidase kit, Siemens Healthcare Diagnostics Inc, New 
York, USA), plasma lactate (Lactate kit, Siemens and serum insulin (Insulin IRI kit, Seimens) 
concentrations, were analysed using a semiautomatic analyser (ADVIA Centaur® System, Bayer 
Diagnostics, Newbury, Berks, UK). The within-run precision (coefficient of variation) for 
plasma glucose, plasma lactate and serum insulin was 0.5 to 0.6%, 1.0 to 1.9% and 3.2 to 4.6%, 
respectively.  
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Statistical Analysis 
Data were tested for normal distribution (Kolmogorov-Smirnov test) and are presented as mean 
± SD. A Friedman two-way ANOVA by ranks was used for the analysis of differences in time to 
exhaustion between trials, as these data were not normally distributed. Where significance was 
detected post hoc analysis was performed using a Wilcoxon signed rank test with Bonferroni 
adjustment (alpha level of 0.0166 per test (0.05/3)). Statistical comparisons for time to 
exhaustion were made using Cohen’s Effect size (ES) with threshold values for small (0.2), 
medium (0.6), large (1.2), very large (2.0) and extremely large (4.0) effects (20). A one-way 
ANOVA was used to assess whether there was an order effect of the randomization of the trials 
for time to exhaustion, as well as the mean of the total area under the curve (AUC) for plasma 
glucose and serum insulin. Two-way ANOVA for repeated measures was used to compare 
differences in blood related variables and heart rate over time and between conditions. Where 
significance was detected for both a one-way and two-way ANOVA post hoc analysis was 
performed using a paired t-test with Bonferroni adjustment to establish differences between 
conditions and condition and time interactions (alpha level of 0.0166 per test (0.05/3)). A 
Friedman two-way ANOVA by ranks was used to analyse differences in RPE over time as well 
as between conditions. A Wilcoxon signed rank test, with Bonferroni adjustment (alpha level of 
0.0166 per test (0.05/3)) was used to analyse the interaction between time and condition. Only 
the eight participants who completed 65 minutes of the exercise protocol (period over which 
these variables are reported) had their blood related variables, heart rate and RPE evaluated using 
SPSS for Windows version 17 (Chicago, USA). A 0.95 level of confidence was predetermined to 
denote statistical significance (P<0.05).  
 
 
Pre-exercise Galactose Ingestion                 10 
 
RESULTS 
Time to Exhaustion 
The pre-exercise ingestion of Gal produced longer times to exhaustion than Glu [68.7 ± 10.2 
minutes vs. 58.5 ± 24.9 minutes, ES = 0.68, P=0.005 (figure 1)]. In fact, when ranking individual 
responses to Gal and Glu all 10 cyclists produced longer times to exhaustion on Gal, with these 
improvements ranging from 1.4 to 47.1 minutes. There were no differences in time to exhaustion 
between placebo (63.9 ± 16.2 minutes) and glucose (ES = 0.36, P=0.0214) or placebo and 
galactose (ES = 0.27, P=0.0214). There were no differences between results according to the 
randomized order in which the three trials were completed, showing that there was no order 
effect. Eight out of 10 cyclists produced longer times to exhaustion on placebo compared to Glu, 
whilst only two cyclists performed worse than placebo on galactose. Overall there was a range of 
endurance times of 18.5 minutes to 85.9 minutes. Following the ingestion of Gal only one cyclist 
did not complete all ten 90% Wmax sprints fatiguing at 44 minutes. Two cyclists whilst taking Glu 
(one of which was the cyclist reported above) and one of these during placebo did not complete 
any of the sprints, fatiguing during the initial 20 minutes of progressive increases in exercise 
intensity. All cyclists were included in the non-parametric analysis of these data. Further, none of 
the cyclists reported any gastro-intestinal problems prior to or during the exercise period.  
Blood Analyses 
Plasma glucose concentrations increased to 8.0 ± 1.0 mmol·L-1 over the 28 minutes prior to 
exercise following Glu ingestion (P<0.001), which were higher than Gal (5.4 ± 0.5 mmol·L-1, 
P<0.001) and placebo (4.9 ± 0.3 mmol·L-1 (P<0.001, figure 2A)). Following Gal ingestion, there 
was a smaller increase in plasma glucose concentration (0.5 mmol·L-1).  After the onset of 
exercise, plasma glucose concentrations fell rapidly following the ingestion of Glu to a nadir of 
3.9 ± 1.2 mmol·L-1, at 15 minutes into exercise. The decrease in plasma glucose concentrations 
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was less evident following Gal ingestion (nadir 4.4 ± 0.8 mmol·L-1) at 15 minutes into exercise. 
During the placebo condition plasma glucose concentrations remained stable. Plasma glucose 
concentrations fell below the hypoglycaemic threshold of 3.0 mmol·L-1 (12, 33) during the initial 
20 minutes of exercise for three cyclists during the Glu trial, though they did not report any 
symptoms and only one cyclist was unable to continue exercising. After the first 20 minutes of 
exercise, plasma glucose concentrations increased to slightly above baseline concentrations by 
59 minutes (5.5 ± 1.3 mmol·L-1) for Glu, with stability thereafter. During the galactose condition 
no cyclists had plasma glucose concentrations below the hypoglycaemic threshold. Following 
Gal and placebo ingestion plasma glucose concentrations increased to a relative hyperglycaemia 
by 59 minutes (6.7 ± 1.5 mmol·L-1 and 6.9 ± 1.2 mmol·L-1, respectively) and subsequently 
decreased to values comparable to the Glu condition. Even though there were different 
glycaemic patterns of response between conditions, there were no significant differences in the 
mean plasma glucose AUC between conditions (placebo: 486.8 ± 113.8 mmol·L-1·min, Glu: 
487.8 ± 119.2 mmol·L-1·min, Gal: 509.0 ± 62.6 mmol·L-1·min). 
Figure 2B shows that following the ingestion of Glu, serum insulin concentrations 
significantly (P<0.001) increased to peak values of 29.6 ± 15.2 μU·mL-1 at 28 minutes, which 
were higher than insulin concentration following Gal (12.5 ± 6.2 μU·mL-1, P<0.001) and placebo 
(4.5 ± 1.9 μU·mL-1, P<0.001). Concentrations following Gal were also higher than placebo 
(P=0.001). Throughout the initial 20 minutes of exercise serum insulin concentrations decreased 
towards basal values for Glu and Gal. Serum insulin was higher throughout this period during the 
Glu trial, though only significantly so at 35 minutes (19.0 ± 11.9 μU·mL-1) in comparison to Gal 
(6.2 ± 3.5 μU·mL-1, P=0.003) and placebo (3.6 ± 1.5 μU·mL-1, P=0.007).  Thereafter, values then 
converged and remained relatively stable until the end of exercise. The different insulinogenic 
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responses between conditions produced differences in the mean serum insulin AUC between 
conditions, with Glu (897.8 ± 3.15.0 μU·mL-1·min) being significantly greater than placebo 
(339.4 ± 172.8 μU·mL-1·min, P<0.001) and Gal (513.1 ± 170.4 μU·mL-1·min, P=0.011) as well as 
Gal being significantly greater than placebo (P=0.011).  
Plasma lactate concentrations changed over time and increased from typical resting 
values after the initial period of exercise (P<0.001), and then decreased for the remainder of the 
prescribed part of the exercise protocol (figure 2C). Plasma lactate concentrations were higher 
for Gal (1.8 ± 0.7 mmol·L-1) in comparison to Glu (1.2 ± 0.4 mmol·L-1, P=0.002) and placebo 
(1.1 ± 0.3 mmol·L-1, P=0.013) at 28 minutes. Glu produced higher plasma lactate concentrations 
in comparison to placebo at 72.5 minutes (9.4 ± 3.7 vs. 7.7 ± 3.4 mmol·L-1, P=0.009).  
Heart Rate and Ratings of Perceived Exertion.  
Both heart rate (figure 3A) and RPE (figure 3B) showed a predictable pattern of physiological 
responses consistent with exercise at different intensities, with no significant main effect of 
condition or interactions between conditions and time.   
 
DISCUSSION 
The present study demonstrates that the chance of improving performance following the 
ingestion of carbohydrate within the hour of exercise commencing was small in comparison to 
placebo. However, the pre-exercise ingestion of galactose was more effective at maintaining 
endurance capacity in comparison to glucose, producing greater times to exhaustion on all 
occasions. Galactose ingestion produced similar glycaemic responses to placebo during exercise, 
maintaining superior plasma glucose concentrations during the initial phase of the sprints 
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compared to glucose. In contrast, 30% of the cyclists were susceptible to rebound hypoglycaemia 
during the initial 20 minutes of exercise following glucose ingestion, however, only one cyclist 
was sensitive to this and was unable to continue exercising. 
Pre-exercise ingestion of Gal and Glu did not produce a significant endurance capacity 
advantage in comparison to placebo. The latter is in agreement with (22, 43) and also in contrast 
with previous literature (28, 41).  The variation in time to exhaustion within conditions was 
relatively large (CV: placebo 25.4%, Glu 13.3%, Gal 14.8%), which may explain why there are 
no significant differences from the placebo condition for either CHO condition. Nevertheless, 
Gal had a mean difference of +4.7 minutes and Glu -5.5 minutes compared to placebo which 
could be considered physiologically significant. Accordingly, this study supports previous 
concerns over the consumption of glucose as a pre-exercise formulation in comparison to a 
placebo (15, 28) for some individuals.  
The performance advantage of Gal compared to Glu is contrary to the findings of Jentjens 
and Jeukendrup (24). However, that study used a different carbohydrate dose (75g vs. 40g) and 
exercise protocol in comparison to the present study (time trial vs. time to exhaustion). The high-
intensity time to exhaustion protocol used in the present study, though less ecologically valid, 
was deliberately designed to test differences between metabolic aspects of fatigue, which is not 
possible with a time trial design. Time to exhaustion protocols have the advantage of providing a 
controlled environment for the comparison of metabolic variables (10), such as plasma glucose 
concentrations, compared to time trials, which are likely to produce variability in exercise 
intensity. Furthermore, though time trial designs are likely to detect small and potentially crucial 
differences, when combined with small sample sizes may lack adequate statistical power. The 
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present study produced statistical power of 0.5, which is higher than the 0.3 reported by Jentjens 
and Jeukendrup (24).  
The distinct peak in plasma glucose concentration following Glu ingestion, during the 
pre-exercise period (~8 mmol·L-1), was higher in comparison to plasma glucose concentration 
attained following Gal. This is to be expected since plasma glucose concentrations should rise 
following ingestion and absorption of just glucose, but galactose, after absorption, can only be a 
precursor for plasma glucose upon specific metabolism. Circulating glucose enters the muscle 
cell directly where it is converted to glucose-6-phosphate. This may at rest provide sufficient 
substrate for glycogen synthesis but also is “demand led” during exercise to support glycolytic 
flux for energy production. In contrast, on entering the circulation, ingested galactose is 
preferentially taken up by the liver (45), prior to conversion to glucose-1-phosphate through the 
Leloir pathway. Glucose-1-phosphate is then available for the formation of glycogen in the liver 
or is released as free glucose. This may explain the lower postprandial plasma glucose 
concentrations in the pre-exercise period, which is likely to be almost exclusively the controlled 
release of glucose, formed from galactose by the liver, into the circulation (16). This is consistent 
with increases in plasma glucose concentrations of no more than 1 mmol·L-1 reported within a 
galactose tolerance test (50g (16)) or 75g of galactose consumed 45 minutes prior to exercise 
(24).  
The decline in plasma glucose concentrations, albeit from different absolute 
concentrations,  following the appearance of exogenous glucose or galactose reflects a change in 
glucose flux into the muscle during the initial 20 minutes of exercise but the prevalence and 
change was different for each substrate. Hyperinsulinaemia following glucose prior to exercise 
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combined with an effect of increased contractile activity upon exercise on muscle glucose uptake 
would combine to accelerate disposal of plasma glucose (13, 32) at a time when glucose 
production from the liver would be inhibited. During exercise such imbalance between 
production and disposal, if continued, would lead to low glucose concentrations that are 
insufficient to support muscle glucose uptake (27). There is also potentially, as a consequence of 
hyperinsuliaemia, inhibition of lipolysis (21) and also increased reliance on muscle glycogen 
stores (6, 17). All of these likely mechanisms theoretically may explain the significantly shorter 
times to exhaustion following pre-exercise ingestion of Glu compared to Gal, but do not seem to 
influence endurance capacity in comparison to placebo. This suggests that low plasma glucose 
concentrations overall may not be a concern with respect to matching performance on placebo, 
but would be a concern in that it did not improve performance. Even though plasma glucose 
concentrations might be sufficient in the early stages of moderate to high intensity exercise, 
some individuals may be more sensitive than others to this situation(8). Plasma glucose 
concentrations following galactose were far less sensitive to reduction and in contrast the decline 
was also not associated with hyperinsulinaemia. Therefore, the small decline was more likely a 
reflection of increased disposal of plasma glucose into the working muscle upon the initiation of 
exercise (32). Absence of hyperinsulinaemia is unlikely to have suppressed lipolysis and fat 
oxidation. Furthermore, as plasma glucose concentrations were very similar to those produced by 
placebo, Gal ingestion was unlikely to have affected hepatic glucose output during this period. 
Thus, the flux of glucose into the muscle is unlikely to be compromised following galactose 
ingestion. These differences between glucose and galactose in homeostatic balance may underlie 
differences in exercise capacity. Yet differences in individual sensitivity to plasma glucose 
concentration related to insulin concentration and receptor sensitivity may confound simple 
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interpretation and explanation of differences between glucose and galactose conditions. 
However, note that serum insulin AUC was far greater during glucose and under this condition 
exhaustion was likely to occur earlier than under galactose.  
The mean plasma glucose concentrations following the pre-exercise ingestion of Glu (3.9 
± 1.2 mmol·L-1) and Gal (4.4 ± 0.8 mmol·L-1) did not fall below 3.0 mmol·L-1, which has 
previously been defined as hypoglycaemic (12, 33), during the initial 30 minutes of exercise. 
However, 30% of the participants were shown to be below the threshold (3.0 mmol·L-1) and thus 
susceptible to this rebound hypoglycaemia, following the pre-exercise ingestion of Glu. This 
adds to the evidence that rebound hypoglycaemia occurs, but not all individuals appear to be 
susceptible (23, 29). Individual responses appear very relevant. One cyclist in the present study 
only managed to complete 18.5 minutes, following the ingestion of Glu. In this case premature 
fatigue coincided with rebound hypoglycaemia. The cyclist was able to perform for 66.8 minutes 
following the ingestion of placebo. The other two cyclists were able to perform for 75.0 and 66.7 
minutes despite rebound hypoglycaemia, demonstrating some individuals are more sensitive to 
low plasma glucose concentrations than others, as previously suggested (8). Therefore, even 
though research unequivocally supports the consumption of CHO during endurance exercise to 
sustain endurance capacity (25), it may not be to some individuals advantage to consume a 
glucose formulation 30 minutes prior to exercise. Additional research is warranted to evaluate 
those susceptible to rebound hypoglycaemia and whether this has a true effect on endurance 
performance, as well as gauging how many athletes are affected by this phenomenon.  
A feature of the present study is the difference in the recovery of plasma glucose 
concentrations between the three conditions, following the initial 20 minutes of exercise. By the 
third repeat sprint, plasma glucose concentrations increased to a relative hyperglycaemia 
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following the ingestion of placebo and Gal, which was associated with a small increase in plasma 
insulin concentrations. The maintenance of higher plasma glucose concentrations following Gal 
and placebo during the repeated sprints could be explained by either a reduction in plasma 
glucose disposal compared to the Glu condition (unlikely due to the intensity of the exercise), or 
a relative increase in hepatic glucose production/or an adequate hepatic production of glucose. 
The latter hypothesis is particularly attractive for galactose since it is known to be an excellent 
precursor of liver glycogen compared to glucose (11). Therefore, it is possible that the pre-
exercise ingestion of galactose produces during exercise, a situation where the liver is more able 
to maintain plasma glucose concentration a key determinant of muscle glucose uptake, as it is not 
associated with the effects of hyperinsulinaemia or other homeostatic imbalances. The lower 
plasma glucose concentrations, though not below basal concentrations, during the use of Glu are 
likely to be a consequence of the continued inhibition of hepatic glucose output due to the 
enduring effects of hyperinsulinaemia (27, 32). The differences in plasma glucose concentrations 
following galactose and glucose ingestion are unlikely to be related to intestinal absorption, as 
they both share the same transport mechanism. Both galactose and glucose are ‘actively’ 
transported across the brush border membrane into the cell primarily by the same sodium co-
transport system (46). Therefore, the greater times to exhaustion shown for Gal may in part be 
related to the more effective availability of plasma glucose from subsequent hepatic production, 
especially as plasma glucose concentrations have been shown to be important with regards to 
endurance capacity (4, 5). The higher plasma glucose concentrations are likely to reflect more 
effective maintenance of glucose oxidation (19), especially as there is evidence that galactose 
can produce higher exogenous glucose oxidation rates during the latter stages of exercise in 
comparison to glucose (34). This by itself may postpone fatigue (7), alternatively it may reduce 
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reliance on endogenous glycogen stores which could sustain endurance performance more 
effectively than glucose in this scenario. However, these metabolic differences between glucose 
and galactose, do not explain why neither was able to produce greater performances to placebo, 
particularly galactose. Galactose was as effective as placebo at maintaining relatively high 
plasma glucose concentration during the initial repeated sprints. Therefore, with the 
accompanying rise in serum insulin concentrations similar to placebo, it might be logical to 
assume that the rate of glucose uptake by the exercise muscles was similar. This might explain 
why there were no performance differences between these two conditions, with galactose only 
able to match the normal ‘situation’.  
In conclusion, the present study showed that the pre-exercise consumption of galactose 
30 minutes prior to exercise provided stable and higher plasma glucose concentrations 
throughout exercise for metabolism by the exercising muscles, as well as lower insulin 
responses. Further, this study has also highlighted that following pre-exercise ingestion of CHO 
30% of the trained male cyclists were susceptible to rebound hypoglycaemia from Glu in 
comparison to Gal. The hypothesis that pre-exercise galactose ingestion would reduce the 
occurrence of rebound hypoglycaemia compared to glucose ingestion can then be accepted. 
Additionally, the hypothesis that pre-exercise galactose ingestion would produce significantly 
longer times to exhaustion during a high-intensity endurance capacity test in comparison to 
glucose can also be accepted. However, neither CHO treatment enhanced performance in 
comparison to placebo, which remains to be explained.  
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PRACTICAL APPLICATIONS  
The results of the present study show that the ingestion of CHO within the hour before exercise 
alone does not provide a performance capacity benefit. Therefore, if glycogen reserves are 
optimal then the consumption of CHO within the hour before exercise may not be required for 
such an endurance performance scenario.  
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Figures 
Figure 1. Individual time to exhaustion (n=10). Solid Circles represent the mean for each 
condition. *Gal significantly longer than Glu (P=0.005).  
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Figure 2. Plasma glucose (A) serum insulin (B) and plasma lactate (C) concentrations during the 
30 min prior to exercise and during the initial 65 minutes of high-intensity cycling (n=10). Grey 
rectangle indicates 20 minutes of progressive intensity cycling from 70% to 85% Wmax; black 
rectangle with arrows indicates the ten 90 s sprints at 90% Wmax interspersed with 180 s of active 
recovery at 55% Wmax. * Glu significantly higher than Gal and placebo (P<0.001). † Gal 
significantly higher than Glu and placebo (P=0.002 and P=0.013, respectively). ‡ Placebo 
significantly higher than Gal and Glu (P<0.001). # Glu significantly higher than placebo 
(P=0.009).  
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Figure 3. Heart rate (A) and ratings of perceived exertion (B) during the initial 65 minutes of 
high-intensity cycling (n=10). Grey rectangle indicates 20 minutes of progressive intensity 
cycling from 70% to 85% Wmax; black rectangle with arrows indicates the ten 90 s sprints at 90% 
Wmax interspersed with 180 s of active recovery at 55% Wmax.  
